scholarly article | Q13442814 |
P50 | author | Adrian V. S. Hill | Q22278197 |
Sarah Gilbert | Q30513802 | ||
Katie J. Ewer | Q55175778 | ||
Pedro M Folegatti | Q56380092 | ||
Amy Flaxman | Q57433031 | ||
Angela Minassian | Q62748527 | ||
Duncan Bellamy | Q91783422 | ||
Ian Poulton | Q91783430 | ||
Fernando Ramos Lopez | Q92605172 | ||
Alison M. Lawrie | Q109926029 | ||
Celia H Mitton | Q114367905 | ||
P2093 | author name string | Rachel Roberts | |
Chris Ellis | |||
Thomas G Evans | |||
Megan Baker | |||
Catherine Mair | |||
Raquel L Ramon | |||
P2860 | cites work | Cellular immune correlates of protection against symptomatic pandemic influenza. | Q30353819 |
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study | Q30373419 | ||
Influenza vaccine supply, 2005-2006: did we come up short? | Q33283742 | ||
Efficacy of high-dose versus standard-dose influenza vaccine in older adults | Q34433416 | ||
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review | Q34455910 | ||
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years | Q34464975 | ||
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. | Q34699088 | ||
Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA | Q35880984 | ||
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans | Q36014866 | ||
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy | Q36248959 | ||
Homology between avian oncornavirus RNAs and DNA from several avian species | Q36569406 | ||
Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses | Q37690439 | ||
Recombinant MVA vaccines: dispelling the myths | Q38092468 | ||
Immunosenescence: Influenza vaccination and the elderly | Q38207437 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector | Q39592790 | ||
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation | Q39837248 | ||
An avian cell line designed for production of highly attenuated viruses | Q39906835 | ||
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older | Q40151067 | ||
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial | Q42687156 | ||
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. | Q45778868 | ||
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study | Q46876629 | ||
Vaccines for preventing influenza in the elderly. | Q47641366 | ||
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. | Q50308620 | ||
Novel Platforms for the Development of a Universal Influenza Vaccine. | Q52599675 | ||
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. | Q54247364 | ||
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults. | Q55047600 | ||
Economic burden of seasonal influenza in the United States | Q56659921 | ||
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly | Q87232318 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infectious disease | Q18123741 |
drug discovery | Q1418791 | ||
immunology | Q101929 | ||
Viral Vectors | Q57983034 | ||
P304 | page(s) | 33 | |
P577 | publication date | 2019-03-22 | |
P1433 | published in | Vaccines | Q27725508 |
P1476 | title | Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line | |
P478 | volume | 7 |
Search more.